Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Nicotine withdrawal disrupts both foreground and background contextual fear conditioning but not pre-pulse inhibition of the acoustic startle response in C57BL/6 mice.

André JM, Gulick D, Portugal GS, Gould TJ.

Behav Brain Res. 2008 Jul 19;190(2):174-81. doi: 10.1016/j.bbr.2008.02.018. Epub 2008 Feb 20.

2.

The effects of galantamine on nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL/6 mice.

Wilkinson DS, Gould TJ.

Behav Brain Res. 2011 Sep 30;223(1):53-7. doi: 10.1016/j.bbr.2011.04.010. Epub 2011 Apr 14.

3.

Withdrawal from chronic nicotine and subsequent sensitivity to nicotine challenge on contextual learning.

Wilkinson DS, Gould TJ.

Behav Brain Res. 2013 Aug 1;250:58-61. doi: 10.1016/j.bbr.2013.04.053. Epub 2013 May 6.

4.
5.

Nicotine withdrawal disrupts new contextual learning.

Portugal GS, Gould TJ.

Pharmacol Biochem Behav. 2009 Mar;92(1):117-23. doi: 10.1016/j.pbb.2008.11.001. Epub 2008 Nov 10.

6.

Nicotine enhancement of contextual fear conditioning.

Gould TJ, Wehner JM.

Behav Brain Res. 1999 Jul;102(1-2):31-9.

PMID:
10403013
7.

Interactive effects of ethanol and nicotine on learning in C57BL/6J mice depend on both dose and duration of treatment.

Gulick D, Gould TJ.

Psychopharmacology (Berl). 2008 Feb;196(3):483-95. Epub 2007 Oct 30.

8.

Genetic background influences the effects of withdrawal from chronic nicotine on learning and high-affinity nicotinic acetylcholine receptor binding in the dorsal and ventral hippocampus.

Wilkinson DS, Turner JR, Blendy JA, Gould TJ.

Psychopharmacology (Berl). 2013 Jan;225(1):201-8. doi: 10.1007/s00213-012-2808-8. Epub 2012 Jul 27.

9.

Atomoxetine reverses nicotine withdrawal-associated deficits in contextual fear conditioning.

Davis JA, Gould TJ.

Neuropsychopharmacology. 2007 Sep;32(9):2011-9. Epub 2007 Jan 17.

10.

Nicotine enhances both foreground and background contextual fear conditioning.

Davis JA, Porter J, Gould TJ.

Neurosci Lett. 2006 Feb 20;394(3):202-5. Epub 2005 Nov 2.

11.

Mild anxiogenic effects of nicotine withdrawal in mice.

Jonkman S, Henry B, Semenova S, Markou A.

Eur J Pharmacol. 2005 May 23;516(1):40-5.

PMID:
15922326
12.

Affective and somatic aspects of spontaneous and precipitated nicotine withdrawal in C57BL/6J and BALB/cByJ mice.

Stoker AK, Semenova S, Markou A.

Neuropharmacology. 2008 Jun;54(8):1223-32. doi: 10.1016/j.neuropharm.2008.03.013. Epub 2008 Apr 8.

13.

Strain-dependent effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning.

Portugal GS, Wilkinson DS, Kenney JW, Sullivan C, Gould TJ.

Behav Genet. 2012 Jan;42(1):133-50. doi: 10.1007/s10519-011-9489-7. Epub 2011 Aug 6.

14.

Bupropion dose-dependently reverses nicotine withdrawal deficits in contextual fear conditioning.

Portugal GS, Gould TJ.

Pharmacol Biochem Behav. 2007 Dec;88(2):179-87. Epub 2007 Aug 23.

15.

Dissociation of tolerance and nicotine withdrawal-associated deficits in contextual fear.

Gould TJ, Wilkinson DS, Yildirim E, Blendy JA, Adoff MD.

Brain Res. 2014 Apr 22;1559:1-10. doi: 10.1016/j.brainres.2014.02.038. Epub 2014 Mar 2.

16.
17.

Developmental effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning.

Portugal GS, Wilkinson DS, Turner JR, Blendy JA, Gould TJ.

Neurobiol Learn Mem. 2012 May;97(4):482-94. doi: 10.1016/j.nlm.2012.04.003. Epub 2012 Apr 11.

18.

Donepezil reverses nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL/6J mice.

Poole RL, Connor DA, Gould TJ.

Behav Neurosci. 2014 Oct;128(5):588-93. doi: 10.1037/bne0000003. Epub 2014 Jun 9.

19.

Withdrawal from chronic nicotine administration impairs contextual fear conditioning in C57BL/6 mice.

Davis JA, James JR, Siegel SJ, Gould TJ.

J Neurosci. 2005 Sep 21;25(38):8708-13.

20.

Enhancement of acoustic prepulse inhibition by contextual fear conditioning in mice is maintained even after contextual fear extinction.

Ishii D, Matsuzawa D, Fujita Y, Sutoh C, Ohtsuka H, Matsuda S, Kanahara N, Hashimoto K, Iyo M, Shimizu E.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):183-8. doi: 10.1016/j.pnpbp.2009.10.023. Epub 2009 Nov 14.

PMID:
19922757

Supplemental Content

Support Center